Izotropic Corporation
IZO
CNSX
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 684.48% | 165.02% | 75.23% | -74.21% | -91.88% |
| Depreciation & Amortization | -33.09% | -18.33% | -18.31% | -9.22% | 1.24% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 130.59% | 45.50% | 26.89% | -54.01% | -75.43% |
| Operating Income | -130.59% | -45.50% | -26.89% | 54.01% | 75.43% |
| Income Before Tax | -40.74% | 4.58% | -94.61% | 27.34% | 58.38% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -40.74% | 4.58% | -94.61% | 27.34% | 58.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.74% | 4.58% | -94.61% | 27.34% | 58.38% |
| EBIT | -130.59% | -45.50% | -26.89% | 54.01% | 75.43% |
| EBITDA | -140.94% | -49.10% | -29.02% | 54.52% | 76.29% |
| EPS Basic | -24.00% | 14.92% | -75.34% | 32.91% | 61.18% |
| Normalized Basic EPS | 19.79% | 45.49% | -15.61% | 18.47% | 52.36% |
| EPS Diluted | -24.00% | 14.92% | -75.34% | 32.91% | 61.18% |
| Normalized Diluted EPS | 19.79% | 45.49% | -15.61% | 18.47% | 52.36% |
| Average Basic Shares Outstanding | 13.00% | 11.08% | 9.23% | 7.63% | 6.84% |
| Average Diluted Shares Outstanding | 13.00% | 11.08% | 9.23% | 7.63% | 6.84% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |